Wani Arjumand
Wani Arjumand publishes mostly in Molecular Biology, Pharmacology and Cancer Research, on topics such as Drug-Induced Hepatotoxicity and Protection, Nigella sativa pharmacological applications and Chemotherapy-induced organ toxicity mitigation.
- World rank
- #960,050 of 7,710,434 ranked researchers
- Rank in India
- #13,329 of 280,097
- Works
- 26
- Citations
- 1.2k
- Citations per work
- 45.5
What does Wani Arjumand research?
Wani Arjumand's work is mostly in Biochemistry, Genetics and Molecular Biology (40%), Medicine (23%), Pharmacology, Toxicology and Pharmaceutics (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1350.0%
- Everything else727.2%
- Health Sciences622.8%
- Medicine622.8%
- 1Molecular Biology30% of their works
- 2Pharmacology10% of their works
- 3Cancer Research10% of their works
- 4Pathology and Forensic Medicine10% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Complementary and alternative medicine6% of their works
Research topics
- Drug-Induced Hepatotoxicity and Protection
- Nigella sativa pharmacological applications
- Chemotherapy-induced organ toxicity mitigation
- Cancer-related molecular mechanisms research
- Single-cell and spatial transcriptomics
- Glutathione Transferases and Polymorphisms
- Carcinogens and Genotoxicity Assessment
- RNA modifications and cancer
Which keywords describe Wani Arjumand's research?
The keywords of their largest research topics: Oxidative Stress, Antioxidants, Mitochondrial Dysfunction, Cancer, Cisplatin, Drug-Induced Liver Injury, Hepatotoxicity and Nephrotoxicity.
- m6A-seq
- Genotoxicity Testing
- Transcriptomics
- Single-Cell
- Long Noncoding RNAs
- Thymoquinone
- Nephrotoxicity
- Drug-Induced Liver Injury
- Cancer
- Antioxidants
- Oxidative Stress
- Mitochondrial Dysfunction
- Cisplatin
- Hepatotoxicity
- Nigella sativa
- Glutathione Transferases
- RNA Regulation
- Superoxide Dismutase
- Comet Assay
- RNA methylation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Oxidative Stress113 topics
- Antioxidants82 topics
- Mitochondrial Dysfunction82 topics
- Cancer72 topics
- Cisplatin41 topic
- Drug-Induced Liver Injury41 topic
- Hepatotoxicity41 topic
- Nephrotoxicity41 topic
- Nigella sativa41 topic
- Thymoquinone41 topic
- Glutathione Transferases31 topic
- Long Noncoding RNAs31 topic
- RNA Regulation31 topic
- Single-Cell31 topic
- Superoxide Dismutase31 topic
- Transcriptomics31 topic
- Comet Assay21 topic
- Genotoxicity Testing21 topic
- RNA methylation21 topic
- m6A-seq21 topic
Where does Wani Arjumand work?
Wani Arjumand's main affiliation in the publication record is Jamia Hamdard, India.
How many publications and citations does Wani Arjumand have?
OpenAlex counts 26 works and 1,184 citations for Wani Arjumand, an h-index of 18, ranking #960,050 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Wani Arjumand. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.